Your browser doesn't support javascript.
loading
Current pandemic COVID-19 vaccine strategies and development: a comprehensive review
Ullah, Hayat; Raziq, Abdur; Gul, Anbareen; Ullah, Asad; Saeed, Javaria; Iqbal, Navid; Sultan, Imrana Niaz; Tareen, Afrasiab Khan; Hussain, Saadat; Khan, Muhammad Waseem.
  • Ullah, Hayat; Faculty of Life Science, Government College University Faisalabad. PK
  • Raziq, Abdur; Faculty of Life Science, Government College University Faisalabad. PK
  • Gul, Anbareen; Quaid-i-Azam University. Islamabad. PK
  • Ullah, Asad; Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences. Quetta. PK
  • Saeed, Javaria; Institute of Industrial Biotechnology, Government College University Lahore. PK
  • Iqbal, Navid; Institute of Biotechnology and Genetic Engineering, The University of Agriculture Peshawar. PK
  • Sultan, Imrana Niaz; Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences. Quetta. Kasetsart University Chatuchak. Bangkok, Thailand. PK
  • Tareen, Afrasiab Khan; Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences. Quetta. Kasetsart University Chatuchak. Bangkok, Thailand. PK
  • Hussain, Saadat; Faculty of Genomics and Bioinformatics. Aix Marseille University. Marseille. FR
  • Khan, Muhammad Waseem; University of Eastern Finland. Kuopio. FI
Artículo en Inglés | LILACS, CUMED | ID: biblio-1442249
ABSTRACT
The coronavirus disease-19 pandemic with the characteristics of asymptomatic condition, long incubation period and poor treatment has influenced the entire globe. Coronaviruses are important emergent pathogens, specifically, the recently emerged sever acute respiratory syndrome coronavirus 2, the causative virus of the current COVID-19 pandemic. To mitigate the virus and curtail the infection risk, vaccines are the most hopeful solution. The protein structure and genome sequence of SARS-CoV-2 were processed and provided in record time; providing feasibility to the development of COVID-19 vaccines. In an unprecedented scientific and technological effort, vaccines against SARS-CoV-2 have been developed in less than one year. This review addresses the approaches adopted for SARS-CoV-2 vaccine development and the effectiveness of the currently approved vaccines(AU)
RESUMEN
La pandemia de COVID-19, con sus características de condición asintomática, largo periodo de incubación y escaso tratamiento, ha tenido un impacto global. Los coronavirus son importantes patógenos emergentes, específicamente, el coronavirus del síndrome respiratorio agudo severo 2 descubierto recientemente, virus causal de la actual pandemia de COVID-19. Para mitigar el virus y reducir el riesgo de infección, las vacunas son la solución más esperanzadora. La estructura de la proteína y la secuencia del genoma del SARS-CoV-2 se procesaron y proporcionaron en un tiempo récord, lo que ha permitido el desarrollo de las vacunas contra el COVID-19. En un esfuerzo científico y tecnológico sin precedentes, se han desarrollado vacunas contra el SARS-CoV-2 en menos de un año. Esta revisión aborda los enfoques adoptados para el desarrollo de la vacuna contra el SARS-CoV-2 y la eficacia de las vacunas actualmente aprobadas(AU)
Asunto(s)

Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humanos Idioma: Inglés Revista: Vaccimonitor (La Habana, Print) Asunto de la revista: Biologia Molecular / Epidemiología / Microbiologia / Vacinas Año: 2023 Tipo del documento: Artículo País de afiliación: Finlandia / Francia / Pakistán Institución/País de afiliación: Faculty of Genomics and Bioinformatics. Aix Marseille University. Marseille/FR / Faculty of Life Science, Government College University Faisalabad/PK / Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences. Quetta/PK / Institute of Biotechnology and Genetic Engineering, The University of Agriculture Peshawar/PK / Institute of Industrial Biotechnology, Government College University Lahore/PK / Quaid-i-Azam University. Islamabad/PK / University of Eastern Finland. Kuopio/FI

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humanos Idioma: Inglés Revista: Vaccimonitor (La Habana, Print) Asunto de la revista: Biologia Molecular / Epidemiología / Microbiologia / Vacinas Año: 2023 Tipo del documento: Artículo País de afiliación: Finlandia / Francia / Pakistán Institución/País de afiliación: Faculty of Genomics and Bioinformatics. Aix Marseille University. Marseille/FR / Faculty of Life Science, Government College University Faisalabad/PK / Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences. Quetta/PK / Institute of Biotechnology and Genetic Engineering, The University of Agriculture Peshawar/PK / Institute of Industrial Biotechnology, Government College University Lahore/PK / Quaid-i-Azam University. Islamabad/PK / University of Eastern Finland. Kuopio/FI